SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001213900-20-002159
Filing Date
2020-01-30
Accepted
2020-01-30 16:47:28
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO REGISTRATION STATEMENT ff32020a1_tizianalife.htm F-3/A 434356
2 OPINION OF ORRICK (UK) LLP ff32020a1ex5-1_tizianalife.htm EX-5.1 46596
3 CONSENT OF MAZARS LLP ff32020a1ex23-1_tizianalife.htm EX-23.1 3514
4 GRAPHIC image_001.jpg GRAPHIC 12715
5 GRAPHIC image_002.jpg GRAPHIC 19523
6 GRAPHIC image_007.jpg GRAPHIC 2364
7 GRAPHIC image_008.jpg GRAPHIC 2364
8 GRAPHIC image_003.jpg GRAPHIC 2196
9 GRAPHIC image_001.gif GRAPHIC 1639
10 GRAPHIC image_006.jpg GRAPHIC 14062
  Complete submission text file 0001213900-20-002159.txt   561999
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-3/A | Act: 33 | File No.: 333-236013 | Film No.: 20561980
SIC: 2834 Pharmaceutical Preparations